11 September 2024
Interim results Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives for animal health, nutrition and biosecurity is pleased to announce…
GSK plc (LSE/NYSE: GSK) today announced that it has completed the primary objective data analysis from the phase II part of the TH HSV…
10 September 2024
Renold plc (“Renold”, the “Company” or the “Group”) Acquisition of MAC Chain Company Limited (USA and Canada) Renold, a leading international supplier of industrial…
Renold plc (“Renold”, the “Company” or the “Group”) AGM Trading Update Renold, a leading international supplier of industrial chains and related power transmission products,…
9 September 2024
Keystone Positive Change Investment Trust plc (“Keystone” or the “Company”) Legal Entity Identifier: 5493002H3JXLXLIGC563 Company Update In early 2021, Keystone shareholders (the “Shareholders”) approved…
9 September 2024 Assura plc Appointment of CIO Assura plc (“Assura” or the “Company”), the specialist healthcare property investor and developer, has appointed Steven…
6 September 2024
GSK plc (LSE/NYSE: GSK) today announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5) in adults…
5 September 2024
Annual General Meeting Statement Summer 2024 on sale seat capacity at 17.17m seats is 12.4% higher than Summer 2023 and a slight increase on…